Women:men, no. (and %) | 39:16 (71:29) |
Positive family history, no. (and %)† | 17 (32) |
Comedication, no. (and %) | 21 (38) |
Age at onset of illness, yr | 39.9, 36.5 (16.0) |
Age at start of prophylaxis, yr | 51.3, 50.3 (13.9) |
Latency to prophylaxis, yr | 11.4, 6.8 (11.5) |
Prophylaxis duration, yr | 6.7, 3.8 (7.4) |